cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets Nicotinamide N-Methyltransferase in Cardiovascular Diseases:
Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target Nicotinamide Riboside and CD38: Covalent Inhibition and Live Cell Labeling JACS Au Emerging opportunities for nicotinamide N methyltransferase (NNMT) inhibitor clinical translation ScienceDirect Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers Nicotinamide N methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions ScienceDirect A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline: Cell Metabolism
Pay in 4 interest-free payments of $5.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





